Switching from Dupilumab to Upadacitinib: Practice-Informing Evidence from LEVEL UP SWITCH This exclusive video interview with Dr. Christopher Bunick unveils the practice-changing insights of the LEVEL UP SWITCH study, designed…
Read More
Harness the Power of AGE Inhibition for Superior Post-Resurfacing Results A breakthrough split-face study shows that a targeted AGE-inhibitory moisturizer dramatically elevates post-resurfacing skincare outcomes for all skin tones. After…
Read More
Uncovering Hidden Autoimmune Threats In Healed Zoster Sites Sometimes the skin that’s healed from herpes zoster can harbor an unexpected surprise. In two striking cases, patients developed new autoimmune eruptions—discoid…
Read More
Zabalafin’s All-In-One Assault On Inflammation, Infection, Dryness, and Itch Atopic dermatitis has long been driven by a vicious circle—staph overgrowth, immune flare-ups, parched skin, and relentless itch that feed one…
Read More
Check out our all-new JDD Video Abstract from Gary S. Rogers, MD, who discusses Placental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis.
Read More
Why CBD’s Skin-Deep Potential Is Both Promising—And Puzzling For Your Practice Over the past decade, CBD has gone from a niche curiosity to a bona fide buzzword in skincare. Acting…
Read More
Curated by the JDD Editors Missed any of our August highlights? August is our psoriasis issue–a must-read. Catch up with this curated roundup from the JDD Editors—your guide to must-read articles…
Read More
Check Out JDD Corner’s Latest Author Spotlight Our latest Author Spotlight shines on Mark G. Lebwohl, MD, co-author of “Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination…
Read More
Recent Safety and Efficacy Data for Biologics in Psoriasis Treatment options for plaque psoriasis have proliferated significantly in the past decade, with an influx of biologics. With these seemingly interchangeable options,…
Read More
A New Outreach Program Demonstrates How Targeted Education Can Transform Access To Dermatologic Care Since its launch in 2020, DermmunityTM, a community service program run by the USC Department of…
Read More
A Concise Look at the IMMPulse Trial Comparing Apremilast And Risankizumab In Moderate Plaque Psoriasis In a compelling video interview for the Journal of Drugs in Dermatology, Dr. Christopher Bunick…
Read More
Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…
Read More
